Design Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Design Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
  • Design Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$13M, a 17.4% increase year-over-year.
  • Design Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$47.8M, a 34% increase year-over-year.
  • Design Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$66.9M, a 5.61% decline from 2022.
  • Design Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$63.3M, a 78.2% decline from 2021.
  • Design Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$35.5M, a 329% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$66.9M -$3.55M -5.61% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 -$63.3M -$27.8M -78.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 -$35.5M -$27.3M -329% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 -$8.28M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.